These lncRNAs are studied in GC (lnc-GC1), in HCC (H19, HOTTIP), in ALL (H19), and in CRC (HOTTIP), and, according to data communicated for the year 2022 by the GCO (a platform curated by the WHO and the IARC), they are among the tumors with the highest incidence and mortality in the world. Here, H19 is linked to acute lymphoblastic leukemia.